Bloomberg the Company & Products

Bloomberg Anywhere Login

Bloomberg

Connecting decision makers to a dynamic network of information, people and ideas, Bloomberg quickly and accurately delivers business and financial information, news and insight around the world.

Company

Financial Products

Enterprise Products

Media

Customer Support

  • Americas

    +1 212 318 2000

  • Europe, Middle East, & Africa

    +44 20 7330 7500

  • Asia Pacific

    +65 6212 1000

Communications

Industry Products

Media Services

Follow Us

http://www.businessweek.com/ap/2012-07-09/ranbaxy-ceo-planning-expansion-in-us-elsewhere

AP News

Correction: Ranbaxy Laboratories-CEO story


PLAINSBORO TOWNSHIP, N.J. (AP) — In a July 9 story about Indian drugmaker Ranbaxy Laboratories Ltd., The Associated Press erroneously reported that the company will launch a generic version of acne drug Accutane in about six months. The product is slightly different than Accutane and will be sold under the brand name Absorica.


LIMITED-TIME OFFER SUBSCRIBE NOW
 
blog comments powered by Disqus